Fenoterol (CAS 13392-18-2) Suppliers and Product Information

Fenoterol is a selective β2-adrenoreceptor agonist with bronchodilator activity. It was introduced in 1971 for the management of asthma. Fenoterol dilates bronchi and blood vessels, has a pronounced tocolytic action, lowers contractile activity, and reduces uterus tonicity. It is mainly used in premature births and for the management of reversible airway obstruction.

Frequently Asked Questions about Fenoterol

Q: What is the main use of Fenoterol?

A: Fenoterol is primarily used as a bronchodilator in the management of reversible airway obstruction, such as in asthma. It is also used in premature births due to its tocolytic action.

Q: How does Fenoterol work?

A: Fenoterol is a selective stimulant of β2-adrenoreceptors. It dilates bronchi and blood vessels, lowers contractile activity, and reduces uterus tonicity.

Q: What is the chemical classification of Fenoterol?

A: Fenoterol is classified as a resorcinol derivative and a β2-adrenergic agonist.

Q: Are there any brand names for Fenoterol?

A: Yes, Fenoterol is marketed under brand names such as Berotec (as hydrobromide) by Boehringer Ingelheim, Dosberotec, Duovent, Fensol, and Partusisten.